Recent nanotechnological interventions targeting PI3K/Akt/mTOR pathway: A focus on breast cancer

Area of Science:

• Oncology
• Genomics
• Nanotechnology

Background:

• Breast cancer remains a leading cause of mortality in women globally.
• Early detection and treatment significantly improve patient outcomes.
• Advanced stage diagnosis contributes to higher mortality rates, necessitating further research.

Purpose of the Study:

• To review the mechanism and significance of targeting the PI3K/Akt/mTOR pathway in breast cancer.
• To explore novel biomarkers for enhanced breast cancer diagnosis and prognosis.
• To summarize the application of nanotechnological interventions in breast cancer treatment.

Main Methods:

• Review of current literature on breast cancer genomics and proteomics.
• Analysis of the PI3K/Akt/mTOR signaling pathway's role in breast cancer.
• Examination of nanomedicine strategies for targeting this pathway.

Main Results:

• The PI3K/Akt/mTOR pathway is frequently hyperactivated in breast carcinomas, driving tumor growth.
• Genomic and proteomic research may yield crucial biomarkers for early detection.
• Nanotechnology presents promising approaches for targeting the PI3K/Akt/mTOR pathway.

Conclusions:

• Targeting the PI3K/Akt/mTOR pathway is a critical strategy in breast cancer therapy.
• Novel biomarkers and nanotechnological interventions hold potential for improving survival rates.
• Continued research in genomics, proteomics, and nanomedicine is vital for advancing breast cancer care.